Zhejiang Xinguang Pharmaceutical Co.,Ltd.’s Net Profit Rose 6.6% in First Half of 2022

Zhejiang Xinguang Pharmaceutical Co.,Ltd. (浙江新光药业股份有限公司) (300519.SZ) reported a net profit of 60.8 million yuan in the first half of 2022, up 6.6% year-on-year.

Meanwhile, the company posted 170.5 million yuan in revenue, up 6.9% year-on-year.

At the end of the reporting period, it had 901.1 million yuan in total assets and 90.1 million yuan in total liabilities, with a liability-to-asset ratio of 10%.